SCHEMBL21486409

SCHEMBL21486409

COc1ccccc1/C(=C/C(=O)O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.55
NPC1 O15118 5/20 0.55
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
MAPT P10636 2/20 0.49
ALDH1A1 P00352 1/20 0.49
KCNK3 O14649 1/20 0.48
KCNK9 Q9NPC2 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.47
CTSD P07339 1/20 0.47
HTT P42858 1/20 0.47
TP53 P04637 2/20 0.47
GAA P10253 1/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
KMT2A Q03164 1/20 0.47
BCHE P06276 1/20 0.46
SLC6A1 P30531 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23393319 1.00 RAB9A (0.55) RAB9ANPC1CA12CA1CA2
SCHEMBL21486412 0.87 RAB9A (0.56) RAB9ANPC1CA12CA1CA2
SCHEMBL30070785 0.87 RAB9A (0.56) RAB9ANPC1CA12CA1CA2
SCHEMBL29085633 0.86 RAB9A (0.51) RAB9ANPC1CA12CA1CA2
SCHEMBL8937318 0.85 LMNA (0.47) RAB9ANPC1CA12CA1CA2
SCHEMBL8937310 0.85 LMNA (0.47) RAB9ANPC1CA12CA1CA2
SCHEMBL23393427 0.83 NPC1 (0.42) RAB9ANPC1ALDH1A1HTTLMNA
SCHEMBL23393425 0.83 NPC1 (0.42) RAB9ANPC1ALDH1A1HTTLMNA
SCHEMBL24512410 0.80 RAB9A (0.51) RAB9ANPC1CA12CA1CA2
SCHEMBL7823036 0.79 CA12 (0.54) RAB9ANPC1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210155591-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2021-05-27 US disclosed
US-20210155591-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2021-05-27 US disclosed
WO-2019196898-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF 中国科学院大连化学物理研究所 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155591-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF CHRNB2, ADRB2, CHRNB1 RAB9A 609/4885NPC1 4383/4885CA12 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.